AMS 700 Inflatable Penile Prosthesis with and without InhibiZone
Boston Scientific Corp · Decision date Oct 2, 2025
What did the FDA decide?
FDA records N970012/S210 as a supplement to PMA null, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Oct 2, 2025.
FDA approval order statement
changes for the pump to kink resistant tubing bonding process preparation and equipment for TENACIO Pump components at Boston Scientific Corporation (BSC) St. Paul
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Oct 2, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- N970012/S210
- Regulatory pathway
- PMA supplement
- Applicant
- Boston Scientific Corp
- Product code
- JCW
- Decision code
- OK30
- Decision date
- Oct 2, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, penis, inflatable.
- Applicant
- Boston Scientific Corp
- Product code
- JCW
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
N970012/S210 received
Application receipt date recorded by FDA.
N970012/S210 · FDA decision
30-Day Notice
Related devices and submissions
Explore the linked device profile
Other records with product code JCW
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
AMS 700 Inflatable Penile Prosthesis (IPP)N970012/S212 | Boston Scientific Corp | PMA supplement | Sep 14, 2026 | FDA |
| Boston Scientific Corp | PMA supplement | May 18, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Boston Scientific Corp
- Headquarters
- Not reported
- Brand website
- bostonscientific.com
- FDA applicant address
- 100 Boston Scientific Way, Marlboro, MA, 01752
Sources and methodology
- Original FDA record: N970012/S210
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
